Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease ; volume:14 ; number:1 ; day:10 ; month:7 ; year:2014 ; pages:1-8 ; date:12.2014
BMC cancer ; 14, Heft 1 (10.7.2014), 1-8, 12.2014
- Creator
-
Kato, Motoyasu
- Contributor
-
Shukuya, Takehito
Takahashi, Fumiyuki
Mori, Keita
Suina, Kentaro
Asao, Tetsuhiko
Kanemaru, Ryota
Honma, Yuichiro
Muraki, Keiko
Sugano, Koji
Shibayama, Rina
Koyama, Ryo
Shimada, Naoko
Takahashi, Kazuhisa
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-508
- URN
-
urn:nbn:de:1111-2016030417532
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kato, Motoyasu
- Shukuya, Takehito
- Takahashi, Fumiyuki
- Mori, Keita
- Suina, Kentaro
- Asao, Tetsuhiko
- Kanemaru, Ryota
- Honma, Yuichiro
- Muraki, Keiko
- Sugano, Koji
- Shibayama, Rina
- Koyama, Ryo
- Shimada, Naoko
- Takahashi, Kazuhisa
- SpringerLink (Online service)
Other Objects (12)
Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Under the Magnifying Glass: Searching for The Evidence of Pemetrexed in Nonsquamous Nonsmall Cell Lung Cancer
New developments in locally advanced nonsmall cell lung cancer
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Under the Magnifying Glass: Searching for The Evidence of Pemetrexed in Nonsquamous Nonsmall Cell Lung Cancer
New developments in locally advanced nonsmall cell lung cancer
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Under the Magnifying Glass: Searching for The Evidence of Pemetrexed in Nonsquamous Nonsmall Cell Lung Cancer
New developments in locally advanced nonsmall cell lung cancer
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab